Literature DB >> 20011309

Carcinoid and neuroendocrine tumors of the colon and rectum.

T Philip Chung1, Steven R Hunt.   

Abstract

Carcinoid and neuroendocrine tumors of the colon and rectum arise from the amine precursor uptake and decarboxylation (APUD) cells of the intestine. Carcinoid tumors are most commonly found in the gastrointestinal tract and are located in decreasing order of frequency in appendix, ileum, rectum, stomach, and colon. The vast majority of lesions are asymptomatic and are found incidentally during endoscopy. The management of these lesions depends upon the size of the lesion, involvement of the muscularis, location, and presence of metastatic disease. Small lesions (1 cm) can often be treated locally, either endoscopically or transanally. However, larger lesions (> 2 cm) require a formal oncologic resection. Adjuvant therapy is indicated only for metastatic disease, and admirable advances have been made in the realm of chemotherapy for reduction of disease and palliation of the symptoms of carcinoid syndrome. In this article, we discuss the nature of these interesting and uncommon tumors, clinical presentation, treatment options, and prognosis.

Entities:  

Keywords:  Carcinoid; colon; neuroendocrine tumor; rectum

Year:  2006        PMID: 20011309      PMCID: PMC2780103          DOI: 10.1055/s-2006-942343

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  37 in total

Review 1.  The APUD concept and hormone production.

Authors:  A G Pearse
Journal:  Clin Endocrinol Metab       Date:  1980-07

2.  Carcinoid tumors frequently display genetic abnormalities involving chromosome 11.

Authors:  O Jakobovitz; D Nass; L DeMarco; A J Barbosa; F B Simoni; G Rechavi; E Friedman
Journal:  J Clin Endocrinol Metab       Date:  1996-09       Impact factor: 5.958

Review 3.  Approaches to the diagnosis of gut neuroendocrine tumors: the last word (today).

Authors:  I M Modlin; L H Tang
Journal:  Gastroenterology       Date:  1997-02       Impact factor: 22.682

Review 4.  The clinical and laboratory correlates of an increased urinary 5-hydroxyindoleacetic acid.

Authors:  W P Tormey; R J FitzGerald
Journal:  Postgrad Med J       Date:  1995-09       Impact factor: 2.401

5.  Colon carcinoid tumors. A population-based study.

Authors:  C Spread; H Berkel; L Jewell; H Jenkins; W Yakimets
Journal:  Dis Colon Rectum       Date:  1994-05       Impact factor: 4.585

Review 6.  Carcinoid tumors of the gut. Our experience over three decades and review of the literature.

Authors:  J B Marshall; G Bodnarchuk
Journal:  J Clin Gastroenterol       Date:  1993-03       Impact factor: 3.062

7.  Chronic ulcerative colitis complicated by atypical carcinoid tumour.

Authors:  S M Dodd
Journal:  J Clin Pathol       Date:  1986-08       Impact factor: 3.411

Review 8.  Mesenteric occlusive lesion and ileal carcinoids.

Authors:  T F Warner; G O'Reilly; G A Lee
Journal:  Cancer       Date:  1979-08       Impact factor: 6.860

9.  Calcification and fibrosis in mesenteric carcinoid tumor: CT findings and pathologic correlation.

Authors:  L Pantongrag-Brown; P C Buetow; N J Carr; J E Lichtenstein; J L Buck
Journal:  AJR Am J Roentgenol       Date:  1995-02       Impact factor: 3.959

Review 10.  The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification.

Authors:  Günter Klöppel; Aurel Perren; Philipp U Heitz
Journal:  Ann N Y Acad Sci       Date:  2004-04       Impact factor: 5.691

View more
  12 in total

Review 1.  The archaic distinction between functioning and nonfunctioning neuroendocrine neoplasms is no longer clinically relevant.

Authors:  Irvin M Modlin; Steven F Moss; Bjorn I Gustafsson; Ben Lawrence; Simon Schimmack; Mark Kidd
Journal:  Langenbecks Arch Surg       Date:  2011-04-27       Impact factor: 3.445

Review 2.  Beyond adenocarcinoma: MRI of uncommon rectal neoplasms and mimickers.

Authors:  David D B Bates; Maria Clara Fernandes de Paula; Natally Horvat; Shannon Sheedy; Chandana Lall; Zahra Kassam; Perry Pickhardt; Neeraj Lalwani; Dhakshinamoorthy Ganeshan; Iva Petkovska
Journal:  Abdom Radiol (NY)       Date:  2019-11

3.  Epidemiological, clinical and endoscopic characteristics of colorectal neuroendocrine neoplasms: a population-based study in the Netherlands.

Authors:  Ankie Reumkens; Prapto Sastrowijoto; Heike I Grabsch; Danny Goudkade; Chantal le Clercq; Minke Bakker; Eric Keulen; Rogier de Ridder; Wouter W de Herder; Bjorn Winkens; Silvia Sanduleanu; Judith de Vos-Geelen; Ad Masclee
Journal:  Endosc Int Open       Date:  2022-07-15

4.  Rectal and anal canal neuroendocrine tumours.

Authors:  Teresa Raposo André; Margarida Brito; João Geraldes Freire; António Moreira
Journal:  J Gastrointest Oncol       Date:  2018-04

5.  Survival in Patients with High-Grade Colorectal Neuroendocrine Carcinomas: The Role of Surgery and Chemotherapy.

Authors:  Adam C Fields; Pamela Lu; Benjamin M Vierra; Frances Hu; Jennifer Irani; Ronald Bleday; Joel E Goldberg; Garrett M Nash; Nelya Melnitchouk
Journal:  Ann Surg Oncol       Date:  2019-01-31       Impact factor: 5.344

6.  Nonlinear optical microscopy for label-free detection of gastrointestinal neuroendocrine tumors.

Authors:  Lianhuang Li; Liwei Jiang; Zhifen Chen; Deyong Kang; Zhenrong Yang; Xing Liu; Weizhong Jiang; Shuangmu Zhuo; Guoxian Guan; Yongjian Zhou; Jianxin Chen
Journal:  Lasers Med Sci       Date:  2016-06-14       Impact factor: 3.161

7.  Lymph Node Size on Computed Tomography Images Is a Predictive Indicator for Lymph Node Metastasis in Patients with Colorectal Neuroendocrine Tumors.

Authors:  Toshiaki Tanaka; Hiroaki Nozawa; Kazushige Kawai; Keisuke Hata; Tomomichi Kiyomatsu; Takeshi Nishikawa; Kensuke Otani; Kazuhito Sasaki; Koji Murono; Toshiaki Watanabe
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

8.  Incidence and survival patterns of rare anal canal neoplasms using the surveillance epidemiology and end results registry.

Authors:  Cristina Metildi; Elisabeth C McLemore; Thuy Tran; David Chang; Bard Cosman; Sonia L Ramamoorthy; Sidney L Saltzstein; Georgia Robins Sadler
Journal:  Am Surg       Date:  2013-10       Impact factor: 0.688

9.  Metastatic carcinoid tumor presenting as right sided heart failure.

Authors:  Efren Martinez-Quintana; Maria Del Mar Avila-Gonzalez; Laura Suarez-Castellano; Fayna Rodriguez-Gonzalez
Journal:  Int J Endocrinol Metab       Date:  2013-04-01

Review 10.  Management of Gastrointestinal Neuroendocrine Tumors.

Authors:  Rongzhi Wang; Rui Zheng-Pywell; H Alexander Chen; James A Bibb; Herbert Chen; J Bart Rose
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2019-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.